I graduated in Medicine at University of Melbourne then did a University of Melbourne MD; ‘Polymorphic Plasmodium falciparum merozoite surface antigens: temporal patterns of infection, complex genotype analysis and intragenic recombination.’ This was supervised by two outstanding malaria researchers in Ross Coppel and Alan Saul.

In my roles as Director of Clinical Research at Townsville Hospital and Professor of Medicine at JCU, I will be a focal point for developing interactions between laboratory based and clinician researchers. This will build up clinical research leading to substantial opportunities for collaborations in discovery medicine.

My own research involves clinical and laboratory investigations on the role of aspirin in prevention of sepsis as well as interrogating possible treatment for vascular disease by manipulating the lectin complement pathway.

I am working to build a large relational patient outcomes data base using the information contained in Queensland Health data sets. This project is a priority objective of the Tropical Australian Academic Health Centre. We are working towards including the five Hospital and Health Services of Northern Australia in this project.

Teaching

• MD5010: Integrated Clinical Practice Part 1 of 3 (Level 5; TSV)
• MD5020: Integrated Clinical Practice Part 2 of 3 (Level 5; TSV)
• MD5030: Integrated Clinical Practice Part 3 of 3 (Level 5; TSV)
• MD6010: Advanced Clinical Medicine Part 1 of 3 (Level 6; TSV)
• MD6020: Advanced Clinical Medicine Part 2 of 3 (Level 6; TSV)
• MD6030: Advanced Clinical Medicine Part 3 of 3 (Level 6; TSV)

Interests

Research

• Aspirin’s influence on infectious diseases: Sepsis - treatment and prevention; The ANTISEPSIS study - AspiriN To Inhibit SEPSIS. ASPREE substudy, Department of Epidemiology and Preventive Medicine, Monash University. National Institutes of Ageing funded primary infection study of low dose aspirin in elderly patients. (19,000 randomised patients) CIA NH&MRC Project Grant awarded for 2013-2018 APP1041986 $391,879.56
• Effects of aspirin on biofilm formation
• Mannose-binding lectin (MBL) biology and its contribution inflammatory condition pathogenesis.
• Blocking MBL in ischaemia reperfusion injury models with the aim of restricting myocardial and brain tissue loss
• Linkage of patient information to develop and relational patient outcome database [Queensland Disease and Treatment Assessment, QLData]

Experience

• 2017 to 2022 - Adjunct Professor of Medicine, Department of Epidemiology and Preventive Medicine,, Monash University (Melbourne)
• 2004 to 2015 - Associate Professor, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne
• 2003 to 2015 - Staff Infectious Diseases Physician, Victorian Infectious Diseases Service,, Royal Melbourne Hospita
• 2003 - Associate Professor, Faculty of Medicine,, University of Queensland
• 1996 to 2003 - Visiting Scientist., Queensland Institute of Medical Research (Brisbane)
• 1996 to 2003 - Infectious Diseases Physician., Royal Brisbane Hospital
• 1994 to 1995 - NH&MRC Medical Postgraduate Scholar,, Monash University (Melbourne)

Research Disciplines

• Clinical sciences (3202)
• Medical microbiology (3207)
• Statistics (4905)

Socio-Economic Objectives

• Clinical health (2001)
• Public health (2004)

Awards

• 2002 - Australasian Society of Infectious Diseases / Amgen Australia Medical Mycology Research – Travel Grant
• 1994 - •Royal Australasian College of Physicians Advanced Trainees Scientific Award

Fellowships

• 2013 - •Visiting Professor, Cytokines and Inflammation Unit Division of Infection and Epidemiology, Institut Pasteur, Paris
• 2002 - Visiting Professor, Montefiore Medical Centre, New York City

These are the most recent publications associated with this author. To see a detailed profile of all publications stored at JCU, visit ResearchOnline@JCU. Hover over Altmetrics badges to see social impact.

Journal Articles

• Pant N, Rush C, Warner J and Eisen D (2023) Effect of Savirin or Ticagrelor Treatment on the Expression of Commonly Used Reference Genes in Staphylococcus aureus. Microorganisms, 11 (2).
• Campbell A, Dotel R, Braddick M, Britton P, Eisen D, Francis J, Lynar S, McMullan B, Meagher N, Nelson J, O'Sullivan M, Price D, Robinson J, Whelan A, Tong S, Bowen A and Davis J (2022) Clindamycin adjunctive therapy for severe Staphylococcus aureus treatment evaluation (CASSETTE)—an open-labelled pilot randomized controlled trial. JAC-Antimicrobial Resistance, 4 (1).
• Eisen D, Hamilton E, Bodilsen J, Køster-Rasmussen R, Stockdale A, Miner J, Nielsen H, Dzupova O, Sethi V, Copson R, Harings M and Adegboye O (2022) Longer than 2 hours to antibiotics is associated with doubling of mortality in a multinational community-acquired bacterial meningitis cohort. Scientific Reports, 12.
• Pant N, Miranda-Hernandez S, Rush C, Warner J and Eisen D (2022) Effect of savirin in the prevention of biofilm-related Staphylococcus aureus prosthetic joint infection. Frontiers in Pharmacology, 13.
• Pant N, Miranda-Hernandez S, Rush C, Warner J and Eisen D (2022) Non-Antimicrobial Adjuvant Therapy Using Ticagrelor Reduced Biofilm-Related Staphylococcus aureus Prosthetic Joint Infection. Frontiers in Pharmacology, 13.
• Pant N, Wallis S, Roberts J and Eisen D (2022) In vitro effect of synovial fluid from patients undergoing arthroplasty surgery on MRSA biofilm formation. Journal of Antimicrobial Chemotherapy, 77 (4). pp. 1041-1044
• Adegboye O, McBryde E and Eisen D (2021) Tropical Australian health-data linkage shows excess mortality following severe infectious disease is present in the short-term and long-term after hospital discharge. Healthcare, 9 (7).
• Adegboye O, Adekunle A, Pak A, Gayawan E, Leung D, Rojas D, Elfaki F, McBryde E and Eisen D (2021) Change in outbreak epicentre and its impact on the importation risks of COVID-19 progression: a modelling study. Travel Medicine and Infectious Disease, 40.
• Eisen D, Leder K, Woods R, Lockery J, McGuinness S, Wolfe R, Pilcher D, Moore E, Shastry A, Nelson M, Reid C, McNeil J and McBryde E (2021) Effect of aspirin on deaths associated with sepsis in healthy older people (ANTISEPSIS): a randomised, double-blind, placebo-controlled primary prevention trial. The Lancet Respiratory Medicine, 9 (2). pp. 186-195
• Pak A, Adegboye O, Eisen D and McBryde E (2021) Hospitalisations related to lower respiratory tract infections in Northern Queensland. Australian and New Zealand Journal of Public Health, 45 (5). pp. 430-436
• Pak A, Eisen D, McBryde E and Adegboye O (2021) Hospitalisation for lower respiratory tract infection is associated with an increased incidence of acute myocardial infarction and stroke in tropical Northern Australia. Scientific Reports, 11.
• Pant N and Eisen D (2021) Non-antimicrobial adjuvant strategies to tackle biofilm-related Staphylococcus aureus prosthetic joint infections. Antibiotics, 10 (9).

More

ResearchOnline@JCU stores 61+ research outputs authored by Prof Damon Eisen from 2007 onwards.

Current and recent Research Funding to JCU is shown by funding source and project.

Advisory Accreditation: I can be on your Advisory Panel as a Primary or Secondary Advisor.

These Higher Degree Research projects are either current or by students who have completed their studies within the past 5 years at JCU. Linked titles show theses available within ResearchOnline@JCU.

Current

• Psychological intervention for reducing emergency department (ED) representations ?? A randomised controlled trial (RCT) (PhD , Secondary Advisor)
• Environmental and socio-demographic predictors of Bacteraemia in North Queensland (PhD , Secondary Advisor)

Completed

• Development of adjuvant therapy to treat biofilm-related Staphylococcus aureus prosthetic joint infection (2022, PhD , Primary Advisor)

The map shows research collaborations by institution from the past 7 years.
Note: Map points are indicative of the countries or states that institutions are associated with.